Mycophenolate mofetil (Compound)

Synonyms:mycophenolate mofetil, 128794-94-5, CellCept, 115007-34-6, RS 61443, Myfenax, RS-61443, TM-MMF, myclausen, Mycophenylate mofetil, Mycophenolic acid morpholinoethyl ester, Mycophenolatemofetil, Mycophenolate mofetil Teva, CHEBI:8764, 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate, Cellcept (TN), (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, NSC-724229, NSC-758905, 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate, 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate, DTXSID3023340, Mycophenolate mofetil (CellCept), 9242ECW6R0, 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-, Munoloc, Mycophenolate mofetil 100 microg/mL in Acetonitrile, DTXCID103340, MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER, 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate, 2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-, SMR002544686, MMF CellCept(TM), CAS-128794-94-5, HSDB 7436, ME-MPA, SR-05000001485, Mycophenolate mofetil [USAN], Arzip, UNII-9242ECW6R0, Mycophenolatmofetil, Mycophenolate mofetil [USAN:USP], NCGC00159459-02, (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester, mycophenolate-mofetil, Mofetil mycophenolate, MFCD00867568, RS61443, R-99, SCHEMBL4195, CHEMBL1456, MLS003915627, MLS004774133, MLS006011929, SCHEMBL218782, GTPL6831, CHEBI:93612, Mycophenolate mofetil (JAN/USP), HMS2090A03, Pharmakon1600-01504567, MYCOPHENOLATE MOFETIL [JAN], 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester, ACT01993, ALBB-027273, HY-B0199, MYCOPHENOLATE MOFETIL [HSDB], Tox21_111686, BBL029073, BDBM50248299, MYCOPHENOLATE MOFETIL [VANDF], NSC724229, NSC758905, s1501, STL146382, MYCOPHENOLATE MOFETIL [MART.], AKOS005720900, MYCOPHENOLATE MOFETIL [USP-RS], MYCOPHENOLATE MOFETIL [WHO-DD], Tox21_111686_1, AC-1562, BCP9000969, CCG-213315, DB00688, KS-1209, NSC 724229, NSC 758905, MYCOPHENOLATE MOFETIL [EMA EPAR], Mycophenolate mofetil, >=98% (HPLC), NCGC00159459-03, NCGC00159459-04, 140401-05-4, 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate, BM164622, LS-15013, SMR004703518, MYCOPHENOLATE MOFETIL [ORANGE BOOK], MYCOPHENOLATE MOFETIL [EP MONOGRAPH], M2387, MYCOPHENOLATE MOFETIL [USP MONOGRAPH], Mycophenolate mofetil for peak identification, SW219893-1, C07908, D00752, W18801, AB01274794-01, AB01274794-02, AB01274794_03, AB01274794_04, EN300-1705962, A803280, A805863, A888971, J-005626, Q-101316, Q4567614, SR-05000001485-1, SR-05000001485-2, BRD-K92428153-001-01-0, Z2568665233, MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER [MI], Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard, Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard, Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard, Mycophenolate Mofetil, Pharmaceutical Secondary Standard; Certified Reference Material, (1s,3r,4s)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3h-purin-6-one, (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester, 2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE, 2-(4-Morpholinyl)ethyl (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, 2-morpholin-4-ylethyl (E)-6-(6-methoxy-7-methyl-4-oxidanyl-3-oxidanylidene-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoate, 4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E), 6-((7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl))-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester, 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester, morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate, Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
Id:5281078
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Mycophenolate mofetil's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Mycophenolate mofetil.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Mycophenolate mofetil.

This repository is under review for potential modification in compliance with Administration directives.